Tag: consent

  • Followup: Open FDA Investigation on Alleged Non-Consensual Human Experimentation

    Followup: Open FDA Investigation on Alleged Non-Consensual Human Experimentation

    Eager to skip ahead to today’s content?

    Jump to the Table of Contents.

    Good morning, good afternoon, and good evening, Compliance Rockstars, Clinical Research Professionals, Ethics Enthusiasts, Legal Experts, and Investigators!

    330+ subscribers and counting!

    Authored By: Tasha Mohseni

    It’s not often that I post twice in one week.

    But when I do…it’s for a good reason! This is also the first time I am following up on a topic that I have recently written about. I’m unsure how many of you all are also writers, but I love revisiting my old articles. There are several reasons why I enjoy doing this:

    clear light bulb placed on chalkboard
    1. You get to see how your writing style has evolved.
      • You get to see if your writing has improved (or may need improvement). You might even pick up on mistakes you’ve made to correct for next time.
      • Better yet, maybe you will come across something you felt you wrote really well. Maybe you liked how you communicated a certain topic and you want to follow that writing style again.
    2. You get to see how the design of your website has changed.
      • I’m still finalizing my “blog template”, so to speak. In other words, I review my old articles to see how I can optimize my blog layout for my readers.
        • I’m always open to suggestions, so please feel free to reach out!
    3. You can learn a lot by reviewing your old content.
      • Sometimes you can think of new content to generate from old content.
      • Other times, you may challenge your old content. Maybe what you originally wrote is either:
        • Incorrect or
        • You should have thought about it differently

    Without further ado, let’s dive into today’s topic!

    For today, I am going to follow up with my original post regarding the open FDA investigation on alleged non-consensual human experimentation.

    As a general reminder, these are my own interpretations. Any legal information discussed within this post should be discussed with your institution.

    Advertisements

    Table of Contents:

    1. A comment from a subscriber
    2. Let’s review the petition again
    3. A very important lesson is to be learned here
    4. Distinguishing between research and practice
    5. Final Thoughts

    A comment from a subscriber

    A special thank you to Erica Heath for your commentary!

    I’ll say it again for the people in the back, I LOVE receiving feedback from CREST subscribers. When Erica reached out to me, she made a very interesting point:

    "This is very strange. All I see is the petition which, in one page, says nothing and the one page journal entry which is about bad treatment but not research.  Is there a study?  In your analysis, none of these apply if there is no research. There is a significant difference between experimentation and research."

    This was my exact expression…it was as if my mind blew up on itself! It didn’t even dawn on me that there wasn’t a study number referenced. I thought to myself,

    Hmmm…it’s not like me to miss something like that.

    First, I checked to see if there were new documents in the docket. There were none. Then, I thoroughly went through the files within the docket again. No study ID found.

    (Back to the Contents)

    Let’s review the petition again

    This can be reviewed here: FDA-2025-P-5514-0003: Citizen’s Petition Documentation to be attached to Procedural Citizen’s Petition to FDA – Redacted

    As a recap, the petition states:

    • Alleged ongoing use of electrophysiological stimulation and electromagnetic exposure causing pain, seizure-like events, and neurological harm amounting to Electroconvulsive Shock Torture (ECST)
    • ECST is distinct from Electroconvulsive Therapy (ECT) which is a regulated medical treatment
    • Citing federal regulations mentioned above and that human experimentation cannot be performed without consent

    In greater detail, the petitioner states the following methods are being used against her:

    • Electroconvulsive Shock Torture (ECST):
      • Non-consensual, abusive use intended to inflict pain, seizures, cognitive disruption, and trauma
      • Conducted at voltages higher than those used in Electroconvulsive Therapy (ECT), without safegaurds
    • Electromagnetic torture:
      • Pressure, pain, and disruption of neurological processes, including simulated seizures and cardiovascular distress
    • Human-to-Human interface and psychological torment:
      • Harassment, defamation, ridicule, and interference with personal relationships
      • Continuous verbal torment designed to destabilize her socially and psychologically

    (Back to the Contents)

    A very important lesson is to be learned here

    So, no study ID was mentioned. We just verified this. Now, what does this mean?

    When I first saw this petition, I automatically assumed this was human subjects research. I saw “non-consensual”, took it, and ran with it. I saw “FDA investigation” and thought I hit the jackpot. I thought I found a recent research ethics violation case. And maybe I still did. But without that study ID, I can’t assume this is human subjects research.

    (Back to the Contents)

    Distinguishing between research and practice

    Let’s revisit the Belmont Report.

    When I traditionally think of the Belmont Report, I think of only Parts B and C. These parts are where the principles are introduced as well as application of these principles. However, there is another very important part, Part A. In Part A of the Belmont Report, the distinction between research and practice is noted.

    "It is important to distinguish between biomedical and behavioral research, on the one hand, and the practice of accepted therapy on the other, in order to know what activities ought to undergo review for the protection of human subjects of research."

    Let’s define these terms:

    • Practice
      • Refers to interventions that are designed solely to enhance the well-being of an individual patient or client and that have a reasonable expectation of success.
      • The purpose of medical or behavioral practice is to provide diagnosis, preventive treatment or therapy to particular individuals.
    • Research
      • An activity designed to test an hypothesis, permit conclusions to be drawn, and thereby to develop or contribute to generalizable knowledge (expressed, for example, in theories, principles, and statements of relationships).
      • Usually described in a formal protocol that sets forth an objective and a set of procedures designed to reach that objective.

    I’d like to pull another important quote from the Belmont Report:

    "When a clinician departs in a significant way from standard or accepted practice, the innovation does not, in and of itself, constitute research. The fact that a procedure is 'experimental', in the sense of new, untested or different, does not automatically place it in the category of research."

    The report continues with stating that new procedures of this description should be considered formal research at an early stage to determine whether they are safe and effective. Further, it is the responsibility of medical practice committees to insist that a major innovation be classified as research. Research and practice may be carried on together when research is designed to evaluate the safety and efficacy of a therapy. The general rule is that if there is any element of research in an activity, that activity should undergo review for the protection of human subjects.

    (Back to the Contents)

    Final Thoughts

    Unless we know for certain that we are investigating human subjects research, then these research ethic tenets wouldn’t be applicable to this docket.

    If I see another docket of this nature, you bet your bottom dollar that will be the first thing I do. I will see if there is an ethics board and/or study ID mentioned. I also wanted to share some relevant links I found during my research if you’d like to further dive into the topic:

    (Back to the Contents)


    I hope you enjoyed my follow-up post to this open FDA investigation!

  • Why Ethics Matters: Open FDA Investigation on Alleged Non-Consensual Human Experimentation

    Why Ethics Matters: Open FDA Investigation on Alleged Non-Consensual Human Experimentation

    See: Followup: Open FDA Investigation on Alleged Non-Consensual Human Experimentation

    RD Research Services Current Way of Thinking as of 10/30/25

    Eager to skip ahead to today’s content?

    Jump to the Table of Contents.

    Good morning, good afternoon, and good evening, Compliance Rockstars, Clinical Research Professionals, Ethics Enthusiasts, Legal Experts, and Investigators!

    330+ subscribers and counting!

    Authored By: Tasha Mohseni

    It feels so good to be writing, reporting, and sharing my insights with you all again!

    I have a fun fact to share that you may not have known about me. When I was in high school I always thought I would be a journalist. I *almost* wish I pursued that, but I’m glad I didn’t. I only pictured myself as the type of journalist that would be present during a high-stakes car chase. Or maybe even being at the front lines of a natural disaster. Another fun fact about me is that I always wanted to be a blogger. But…I never knew what I would write about. I just knew I wanted to write something meaningful…and useful.

    a woman reporting beside the van

    I had no idea that I could report the type of regulatory updates I do now. Without having gone through what I’ve gone through, I never would have ended up in research compliance. And without this journey, I never would have created this meaning AND useful blog for professionals in our field.

    Speaking of our field, can you think of a recent human research ethics violation? If you know of a recent event, please leave a comment and share a link to promote discussion!

    Leave a Reply

    I tried to think about this some time ago (I want to say last month). Of course I am familiar with the cases that led to the Belmont Report. And I certainly recall some after the Belmont report (e.g., Jesse Gelsinger). Fast forward to last Wednesday. I was browsing Regulations.gov, which is still in operation despite the government shutdown. You can imagine my surprise when I came across the following docket:

    Screenshot from Regulations.gov RE: FDA nonrulemaking docket.

    When I read this, I thought "WHOA!" I couldn't believe my eyes. This sounds to me like a recent human research ethics violation case. Which leads me to today's topic. Today, I'm going to cover this request for an FDA investigation. Specifically, I will:

    • Introduce the case prompting investigation
    • Share my thoughts on which ethical tenets were violated based on the intial petition
    • Review the remaining documents associated with this docket
    • Close the article with my concluding thoughts

    As a general reminder, these are my own interpretations. Any legal information discussed within this post should be discussed with your institution.

    Advertisements

    Table of Contents:

    1. Citizen Petition from Kimberly C. Tanner
    2. Initial Ethical Analysis
      1. Nuremberg Code
      2. Belmont Report
      3. ICH GCP E6(R3)
      4. Declaration of Helsinki
    3. Review of Remaining Documentation within the FDA Docket
      1. The "Good Science" Article
      2. The Legal Dagger
      3. The Coup De Gras
    4. Closing Thoughts

    Citizen Petition from Kimberly C. Tanner

    This can be reviewed under FDA-2025-P-5514-0001.

    In summary, the petition states:

    • The FDA to complete the following actions:
      • Initiate an investigation and oversight review into alleged non-consensual human experimentation and Electroconvulsive Shock Torture (ECST) conducted through the misuse of electrophysiological and neuromodulation technologies
      • Issue a Federal Register notice clarifying that the non-therapeutic use of electroconvulsive shock and electromagnetic neuromodulation devices outside approved research or clinical contexts constitutes a violation of human-subject protections under the Common Rule(45 CFR 46) and FDA device regulations (21 CFR Parts 50 and 56)
      • Review and revoke, where appropriate, device clearances or research exemptions that enable non-consensual human application of electrophysiological stimulation
    • The petition is then backed by the following claims:
      • Alleged ongoing use of electrophysiological stimulation and electromagnetic exposure causing pain, seizure-like events, and neurological harm amounting to Electroconvulsive Shock Torture (ECST)
        • The petitioner has journal records indicating this and is conssistent with electrophysiological stimulation under UN Convention Against Torture and the Istanbul Protocol (2022)
      • ECST is distinct from Electroconvulsive Therapy (ECT) which is a regulated medical treatment
      • Citing federal regulations mentioned above and that human experimentation cannot be performed without consent

    (Back to Contents)

    Initial Ethical Analysis

    I immediately thought of four ethical frameworks once I read the petition.

    I'd like to walk through each of these frameworks and share my analysis as it relates to the case.

    Nuremberg Code

    How does this NOT violate every entry in the Nuremburg Code?

    Though there isn't a reason to walk through each statement one by one, I feel we should. Each statement has its own impact to the case:

    • "The voluntary consent of the human subject is absolutely essential. This means that the person involved should have legal capacity to give consent; should be situated as to be able to exercise free power of choice, without the intervention of any element of force, fraud, deceit, duress, over-reaching, or other ulterior form of constraint or coercion, and should have sufficient knowledge and comprehension of the elements of the subject matter involved as to enable him to make an understanding and enlightened decision. This latter element requires that before the acceptance of an affirmative decision by the experimental subject there should be made known to him the nature, duration, and purpose of the experiment; the method and means by which it is to be conducted; all inconveniences and hazards reasonably to be expected; and the effects upon his health or person which may possibly come from his participation in the experiment.

      The duty and responsibility for ascertaining the quality of the consent rests upon each individual who initiates, directs or engages in the experiment. It is a personal duty and responsibility which may not be delegated to another with impunity."
      • This one is self explanatory as this is one of the claims against the alleged party
    • "The experiment should be such as to yield fruitful results for the good of society, unprocurable by other methods or means of study, and not random and unnecessary in nature."
      • You will see my rationale behind this as I explore the other documents within the investigation. I can assure you this was not based on "good science".
    • "The experiment should be so designed and based on the results of animal experimentation and a knowledge of the natural history of the disease or other problem under study that the anticipated results will justify the performance of the experiment."
      • This doesn't sound applicable based off the files within the docket.
    • "The experiment should be so conducted as to avoid all unnecessary physical and mental suffering and injury."
      • I believe the name of this petition explains enough as to why this statement is in direct violation.
    • "No experiment should be conducted where there is an a priori reason to believe that death or disabling injury will occur; except, perhaps, in those experiments where the experimental physicians also serve as subjects."
      • Again, the docket's title is plenty of explanation for this statement's violation.
    • "The degree of risk to be taken should never exceed that determined by the humanitarian importance of the problem to be solved by the experiment."
      • Self explanatory...
    • "Proper preparations should be made and adequate facilities provided to protect the experimental subject against even remote possibilities of injury disability or death."
      • This relates to the "good sciences" article.
    • "The experiment should be conducted only by scientifically qualified persons. The highest degree of skill and care should be required through all stages of the experiment of those who conduct or engage in the experiment."
      • A blend of being "self explanatory" and "good science".
    • "During the course of the experiment the human subject should be at liberty to bring the experiment to an end if he has reached the physical or mental state where continuation of the experiment seems to him to be impossible."
      • Given that consent was acquired, it's safe to assume that the participant wasn't given any liberties.
    • "During the course of the experiment the scientist in charge must be prepared to terminate the experiment at any stage, if he has probable cause to believe, in the exercise of the good faith, superior skill and careful judgement required by him that a continuation of the experiment is likely to result in injury, disability, or death to the experimental subject."
      • Again, a blend of being "self explanatory" and "good science".

    (Back to Contents)

    Belmont Report

    This can be reviewed here: Belmont Report.

    I immediately saw that this was in direct violation of two out of the three tenets:

    • Respect for Persons
      • Violating informed consent is in direct violation of this principle.
      • Specifically, violating the fact that folks are autonomous agents and that consent must be voluntarily given to be valid.
    • Beneficence
      • Though it is unclear what any benefits would be from this study, potential harms were not minimized.
      • This also ties into violation of the Hippocratic Oath, which is foundational to medical ethics.

    (Back to Contents)

    ICH GCP E6(R3)

    This can be reviewed here: ICH GCP E6(R3).

    Of course, this is under the assumption that this was a clinical trial:

    • "Clinical trials should be conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki and that are consistent with GCP and applicable regulatory requirement(s). Clinical trials should be designed and conducted in ways that ensure the rights, safety and well-being of participants."
      • I won't dive further into this since I already mentioned the Declaration of Helsinki.
    • "Informed consent is an integral feature of the ethical conduct of a trial. Clinical trial participation should be voluntary and based on a consent process that ensures participants (or their legally acceptable representatives, where applicable) are well-informed."
      • Again, one of the most compelling elements of this case.
    • "Clinical trials should be subject to an independent review by an IRB/IEC."
      • This ties into the "good science" article.
    • For principles 4-11:
      • See bullet point above.

    (Back to Contents)

    Declaration of Helsinki

    This can be reviewed here: Declaration of Helsinki.

    Not that I want to take shortcuts here, but in case you didn't know there are 30+ tenets! It's safe to say that there is a lot of overlap with these ethical principles. For the sake of not being repetitive, we can assume this case violated the Helsinki tenets. I can only imagine if we walked through each principle how long this post would be!

    (Back to Contents)

    Review of Remaining Documentation within the FDA Docket

    I'm curious of how spot on my analysis is now that we are going to review other critical documents.

    Let's deep dive into the other elements of the case.

    The "Good Science" Article

    Here is the article: Bad Science Used to Support Torture and Human Experimentation.

    In short, this relates to FDA-2025-P-5514-0004: Exhibit E-9 โ€” Misuse of Science in Torture Justifications. Upon review:

    • Exhibit E-9 discusses why Bad Science Used to Support Torture and Human Experimentation article is not "good science".
    • The "good science" articles details how the Office of Medical Services (OMS) and affiliated behavioral scientists falsely claimed scientific validation by referencing internal field reports and memoranda as though they were controlled studies.
      • The science used to justify torture was bad because it repeatedly failed to assess important long-term physical and mental health outcomes.
      • To avoid this from happening again, recommendations with respect to the following topics were provided:
        • Independence and accountability
        • Peer review and monitoring
        • Training and education
        • Government accountability
    • Further, per Exhibit E-9:
      • This misuse of empirical language gave policy-makers a pseudo-scientific justification to continue torture while claiming medical supervision.
      • The OMSโ€™s interpretation of physiological data ignored established neurobiological evidence showing that severe stress, hypoxia, and sleep deprivation cause long-term neurocognitive and psychological injury.
      • By reclassifying human suffering as โ€œdata,โ€ medical personnel violated:
        • The Nuremberg Code (1947),
        • The Declaration of Helsinki, and
        • The U.S. Common Rule (45 CFR 46)
      • The authors emphasize that no circumstanceโ€”national security, emergency, or warโ€”permits deviation from these ethical standards.

    (Back to Contents)

    Here, I reviewed the following documents:

    The first document complements FDA-2025-P-5514-0001 within the docket (associated with the original petition). Nature of violations described in greater detail (see image below):

    Initial legal and ethical frameworks were also introduced (see image below):

    For the second document:

    • This describes the complete legal framework for the case (i.e., regulations that are relevant to the docket).
    • Details can be reviewed within the file, to summarize:
      • The alleged experiments and interventions(electroconvulsive shock, electromagnetic fields, human-to-human neural interfacing) clearly fall under โ€œresearch involving devices or procedures not clinically approved.โ€
      • Due to no informed consent, IRB review, device labeling, or IDE authorization, actions described here directly violate 45 CFR 46 and 21 CFR 812.
      • These violations are compounded when the procedures are used as instruments of torture (i.e., they violate both human-rights and regulatory law).

    (Back to Contents)

    The Coup De Gras

    This reviews FDA-2025-P-5514-0007: Torture Journal Entry by Kimberly C. Tanner 10-17-25.

    In essence, this incredibly vivid journal entry describes the torture Kimberly C. Tanner went through during these experiments. I'd like to use these next couple of bullet points solely to highlight direct quotes from the journal entry. In my opinion, these horrific statements speak to the importance of this FDA investigation and the magnitude of the situation.

    • "Fearmongering is a factor, but real fear is at play since I have no idea how many years this will take off my life, how much damage is being done to my brain and the rest of my body including other organs of my body since no part of my body is off limits to Operator #1, who also has no conscience and behaves maliciously most of the time."
    • "Iโ€™d like to also add that non-consensual human-human interfacing is molestation in and of itself."

    (Back to Contents)

    Closing Thoughts

    This song played in my head as soon as I formatted this section:

    "Closing time, you don't have to go home but you can't stay here"

    handwritten message on brown background

    I'm thinking this must have been a FDA-regulated study (given the device regulations that were cited. However, I also wonder if this was DOD-sponsored research. One of the ethical/legal frameworks that was mentioned within the case was specific to DOD. I wonder if it is safe to assume that this isn't a clinical trial (given ICH GCP E6(R3) guidelines weren't mentioned). I know that I'm not a lawyer. However, I did have fun analyzing this case. It's amazing that these ethical principles that were applied to human rights violations in the 1940s still hold true today.

    Just as the image says, human rights are not optional. Participant protections are not optional. This is why myself (and other professionals within our field) hold these ethical tenets so close to heart.

    (Back to Contents)


    I hope you found this post thought-provoking and insightful!

  • June 2025: RAC Digest

    June 2025: RAC Digest

    Good morning, good afternoon, and good evening, Compliance Rockstars, Clinical Research Professionals, Ethics Enthusiasts, Legal Experts, and Investigators!

    300+ subscribers and counting!

    Welcome to the RAC Digest!

    RAC stands for “Research Administration and Compliance”.

    The RAC Digest will feature select publications from the previous month.

    • These 10 articles will come from journals related to research administration and research compliance.

    As a general reminder, these are my own interpretations. Any legal information discussed within this post should be discussed with your institution.

    If your institution does not have access to the publications listed below and you would like access, please fill out the form below:

    โ† Back

    Thank you for your response. โœจ

    IMPORTANT NOTICE:

    Please note the following articles listed below, the blog author was granted permission to summarize key points ONLY. It will be notated if interested folks can contact the authors for a copy of the article or if the article can’t be shared for other purposes (other than for discussing general key points in this post):

    1. Privacy, Policy, and Profits: Survey of Patient Preferences for Research on De-Identified Biosamples – please email Dr. Marielle S. Gross, MD, MBE if you would like to review the article
    2. The Black Prisoners of Stateville: Race, Research, and Reckoning at the Dawn of Precision Medicine – individuals without institutional access to this article may contact the authors for a copy (contact information located within the article)
    3. Content and Readability of Informed Consent Documents Approved by Research Ethics Committees of Health Institutions in South-East Nigeria – this article can’t be shared for other purposes
    Advertisements

    Let’s get started:


    • While Western informed consent (IC) models emphasize individual autonomy, IC models in many Global South communities (e.g., Ghana) focus on collectivist cultural norms
    • Findings of the study led to the development of an IC and participant recruitment framework, including the following four steps:
      • Community entry
      • Independent mediation at households
      • Invitation of eligible participants
      • Multi-step recruitment approach
    • The study illustrates how individual autonomy can be effectively used in sociocultural contexts where decision-making is relational (i.e., in communities)

    Comfort of Sexual and Behavioral Health Survey Research Participation among Undergraduate Students: Findings from a Random Sample of a Southern University

    • The majority of undergraduate students surveyed reported feeling somewhat or very comfortable answering online survey questions related to sensitive topics such as:
      • Alcohol use,
      • Drug use, and
      • Mental health
    • Though fewer students reported comfort with questions about sexual behaviors, researchers found that students who used alcohol before or during sex were over six times more likely to be comfortable answering sexual behavior questions
      • There were no other major demographic factors influencing comfort levels on these topics
    • Based on these findings, research of this nature can meet the CFRโ€™s minimal risk standard and may be evaluated as exempt, rather than expedited, IRB review
      • However, this should be evaluated on a case-by-case basis (given the researcher’s study sample was somewhat small and homogenous)

    Empowering Research Teams: A
    Guide to Effective Post-Award
    Management Training for Principal
    Investigators and Research Staff

    • This article how to develop an effective post-award management training for principal investigators and research staff
    • Post-award training should encompass:
      • Teaching research teams why something is important and necessary
      • Opportunities for hands-on skill building related to post-award management
      • How-to documents, written guidelines, forms, and contact information to assist the research team
    • Lastly, the training content and needs should be tailored towards your institution

    Privacy, Policy, and Profits: Survey of Patient Preferences for Research on De-Identified Biosamples

    • The study aims to identify patient preferences to inform ethical frameworks, policies, and technologies for advancing biobanking and precision medicine
    • A significant portion of participants preferred receiving research results that could impact their health
      • This especially held true if these research results impacted their family’s health
      • Research results were desired even if it meant being re-identified
    • Over half of the participants stated they would prefer maximizing working with for-profit companies to speed the development of new cancer treatments
    • Participants expressed strong preference in being informed if their donated tissues are in high demand
      • They also stressed that they should have a say in how their samples are used, especially when researchers are in competition for their samples

    Modernizing Research and Evidence Consensus Definitions: A Food and Drug Administrationโ€“National Institutes of Health Collaboration

    Advertisements

    Developing, implementing, and transferring a faculty-led RCR training program

    • Virginia Techโ€™s division of Scholarly Integrity and Research Compliance (SIRC) developed an โ€œInvestigator Series” to fulfill the RCR training requirement
      • This series invites investigators to examine the ethical dimensions of their research and lead conversations about how they address these issues in their daily work
      • This proactive approach provides real-life dilemmas and solutions (in lieu of being a check-the-box compliance activity for an institution’s RCR program)
    • RCR coordinator identify faculty who might be interested in presenting for the series and provide consultations to explain the goal of these presentations: provide insights into the decisions that were made to facilitate ethical research
    • The RCR coordinator also serves as the presentation moderator to provide introductory key points about ethical research
      • Further, they ensure that discussion and questions about the presentation remain framed around the central topic of conducting ethical research

    Bots, scammers, and fraudulent responders: a year of disrupted data collection

    • The study highlights how bots, scammers, and fraudulent responses can compromise the integrity of research leading to harmful/ineffective policies and/or interventions
    • Common fraud prevention methods (e.g., CAPTCHA, trick questions, IP tracking, and attention checks) are increasingly ineffective against evolving bots that incorporate AI
    • The article further describes the ethical trade-offs with online research
      • One example mentioned was the verification of participant identities via social media (as participants may feel that researchers have violated their confidentiality by searching for them online or violated of trust)
    • Though a manual process, the paper suggests the following in evaluating the truthfulness of survey responses, e.g.,
      • Using the standard methods mentioned above along with reviewing for consistency/duplication of survey responses, grammar issues in survey responses, and the time to complete the survey

    Disclosing generative AI use for writing assistance should be voluntary

    • This paper indicates that mandatory disclosure policies are unnecessary, can lead to tensions, and are overall counterproductive
    • As an example, the authors state how the assistance of AI for spelling and copy editing doesn’t meet the requirements for formal recognition as the tool didn’t assist with content generation
    • It is also the authors’ concern that investigators will include a blanket statement that the investigator used AI to assist with writing, but not specifically being transparent of how AI was used to assist with writing

    The Black Prisoners of Stateville: Race, Research, and Reckoning at the Dawn of Precision Medicine

    • This paper discussed that Black prisoners were integral to the Stateville studies, providing the crucial data about adverse drug reactions (as opposed to the viewpoint that only White prisoners were of interest)
    • Stateville researchers localized primaquine (antimalarial) sensitivity to a genetic disorder resulting in reduced activity of the enzyme glucose-6-phosphate dehydrogenase (G6PD)
      • Decreased enzyme activity renders individuals unable to combat the oxidative stress triggered by exposure to antimalarial drugs
    • The researchers not only studied the Black prisoners, but also recruited their family members to study the inheritance pattern in a coercive manner
    • Lastly, the article stresses the lack of accessibility of G6PD testing in certain communities
      • The World Health Organization (WHO) recommends G6PD testing to protect those who are G6PD deficient as part of antimalarial campaigns; however, financial barriers and other challenges inhibit this
    • This study assessed the content and readability of the 241 informed consent documents (ICDs) approved for biomedical research in South-East Nigeria from 2019 to 2021
    • A vast majority of the ICDs lacked the basic elements of informed consent (as outlined in the Common Rule)
      • Further, the readability for ICDs were below recommended standards
    • The paper recommends that institutions train researchers and ethics committee members on how to write clear and concise ICDs that are easy to read and understand

    I hope you found this content useful!

    Advertisements
  • Subscriber Spotlight: Preparing a Readable Consent Form

    Subscriber Spotlight: Preparing a Readable Consent Form

    Authored by:

    Mila Babaev

    Reviewed by:

    Tasha Mohseni

    Good morning, good afternoon, and good evening, Compliance Rockstars, Clinical Research Professionals, Ethics Enthusiasts, and Investigators! 260+ blog subscribers and counting!

    I hope everyone is doing well! I can’t believe we are already halfway through 2025. If you’ve been subscribed to the blog from the beginning, you know that I have always promoted collaboration. I love to feature guest authors in my blog.

    Check out the collaborative posts that have been published thus far listed below!

    To highlight these contributors moving forward, I have developed a new type of post called “Subscriber Spotlight”.

    For these posts, you can expect to see:

    • An introduction of the valued subscriber,
    • How long the individual has been a subscriber,
    • Relevant social media and/or publications, and
    • A brief description of what they would like to share with you all!

    As a general reminder, these are solely the author’s interpretations (and none of their employer or associated affiliations). Any legal information discussed within this post should be discussed with your institution.

    Let’s get started:


    Who is Mila Babaev?

    Mila Babaev, CIP has been a loyal subscriber since December 2024. Per her LinkedIn profile:

    • She is an IRB and Compliance professional with over a decade of experience supporting Principal Investigators and study teams.
    • Further, she is versed in federal, state, and institutional level regulations and policy pertaining to the protection of humanโ€subjects research.
    • She is currently pursuing a Masterโ€™s degree in Research Administration and Compliance
      • Her goal is to gain new knowledge from this degree and move into a management role.
    • Lastly, she was recently given the opportunity to conduct internal audits/quality reviews on research trials at Atlantic Health System.

    Let’s dive into her piece on “Preparing a readable consent form”.

    Relevant regulatory requirement

    In reference to research consent forms, 45 CFR 46.116, requires that:

    โ€œThe information that is given to the subject or the legally authorized representative shall be in language understandable to the subject or the legally authorized representative.โ€

    • However, many consent forms submitted to the IRBs I have worked for in my 10 years as an IRB administrator contain language which far exceeds the 6th-8th grade recommended language.
    • The literature is in line with my experience; a review of written consent forms in 2018 revealed that most are written at a 10th grade reading level or higher across all medical specialties.

    In my conversations with researchers, it became clear that some do not even realize the terms aren’t in Layman’s terms.

    The guidance offers two useful ways to detect whether there is an issue with lay language and readability, in general…

    1. Read the form out loud to others and gather feedback
    2. Check grade level via a word processing tool, such as Microsoft Word

    To check the readability via Microsoft Word:

    1. On the โ€œFileโ€ tab, click the โ€œOptionsโ€ button
    2. Then, on the โ€œProofingโ€ tab, under โ€œWhen correcting spelling and grammar in Wordโ€, make sure โ€œCheck grammar with spellingโ€ is selected
    3. Next, under โ€œWhen correcting spelling and grammar in Wordโ€, select the โ€œShow readability statisticsโ€ check box
    4. After the grammar check is complete, Word displays a message box showing you the readability grade-level

    This tool can be valuable to researchers as well as IRB members when completing their reviews.

    Of course, it would be wonderful to have a tool that pinpoints exactly which words need to be defined in lay terms, so that none are missed. With the current AI wave, I think a tool designed for this purpose can be developed. At present, ChatGPT seems to do a decent job. I copy/pasted all the language in this text up to this point into ChatGPT and posed the question Is any of this language not in lay terms, appropriate for 6th-8th grade reading level? Quite a few responses came up, amongst them โ€œlegally authorized representative.โ€


    You can see other key readability tips outlined in the Johns Hopkins article below:

    • Use active verbs
    • Write concise sentences; You can divide one sentence into two
    • Limit each paragraph to one idea
    • Keep words to three syllables or less, if possible
    • Describe study design procedures such as โ€œdouble blind,โ€ and โ€œplacebo/controlledโ€ at first use

    References

    1. 45 CFR 46.116
    2. Johns Hopkins Informed Consent Guidance-How to Prepare a Readable Consent Form
    3. Hadden, K. B., Prince, L. Y., Moore, T. D., James, L. P., Holland, J. R., & Trudeau, C. R. (2017). Improving readability of informed consents for research at an academic medical institution. Journal of Clinical and Translational Science, 1(6), 361โ€“365. doi:10.1017/cts.2017.312

    We hope you found this content useful!

    Thank you again, Mila, for your continued support of this blog! Sharing your knowledge with the research and compliance community is truly appreciated. Looking forward to more collaboration with you on human research.